SCHEMBL876218

SCHEMBL876218

CCCCCCC1OCC(C)O1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
PRKD3 O94806 2/20 0.49
PRKCG P05129 2/20 0.49
PRKCB P05771 2/20 0.49
PRKCA P17252 2/20 0.49
PRKCH P24723 2/20 0.49
PRKCI P41743 2/20 0.49
PRKCE Q02156 2/20 0.49
PRKCQ Q04759 2/20 0.49
PRKCZ Q05513 2/20 0.49
PRKCD Q05655 2/20 0.49
PRKD1 Q15139 2/20 0.49
ENPP2 Q13822 11/20 0.47
LPAR2 Q9HBW0 8/20 0.47
EPHX1 P07099 1/20 0.44
EBP Q15125 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22971838 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL20990982 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3505696 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3504683 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3504699 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL8642826 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL31632757 1.00 ALDH1A1 (0.57) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL873344 0.98 ALDH1A1 (0.54) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3504388 0.92 ALDH1A1 (0.45) ALDH1A1PRKD3PRKCGPRKCBPRKCA
SCHEMBL14272692 0.92 ALDH1A1 (0.45) ALDH1A1PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250261684-A1 SMOKELESS TOBACCO PRODUCT FOR ORAL USE AND SOFT CAPSULE USED THEREIN SUNSHO PHARMACEUTICAL CO., LTD. (JP) 2025-08-21 US disclosed
US-20250120427-A1 CARYOPHYLLENE-CONTAINING COMPOSITION SUNSHO PHARMACEUTICAL CO., LTD. (JP) 2025-04-17 US disclosed
WO-2025070466-A1 SEAMLESS CAPSULE FOR ORAL CAVITY 森下仁丹株式会社 2025-04-03 WO disclosed
EP-4420534-A1 SMOKELESS TOBACCO PRODUCT FOR ORAL USE AND SOFT CAPSULE USED THEREIN Sunsho Pharmaceutical Co., Ltd. (JP) 2024-08-28 EP disclosed
US-20240277012-A1 DUPLICATE BEVERAGE WANG JIE (US) 2024-08-22 US disclosed
EP-4403170-A1 CARYOPHYLLENE-CONTAINING COMPOSITION Sunsho Pharmaceutical Co., Ltd. (JP) 2024-07-24 EP disclosed
CN-113316398-B Seamless capsule, filter and smoking article comprising same 三生医药株式会社 2024-06-11 CN disclosed
US-20240180219-A1 SEAMLESS CAPSULE STABLY DISINTEGRABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING THE SAME MORISHITA JINTAN CO., LTD. (JP) 2024-06-06 US disclosed
EP-3888475-B1 SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME SUNSHO PHARMACEUTICAL CO LTD (JP) 2024-04-10 EP disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
WO-2012039516-A1 DEODORANT COMPOSITION FOR SULFIDES TAKASAGO INTERNATIONAL CORPORATION (JP) 2012-03-29 WO disclosed
US-8066977-B2 Agent for permanent hair waving containing heterocyclic mercapto compound SHOWA DENKO K.K. (JP) 2011-11-29 US disclosed
US-7964637-B2 Process for producing optically active theaspirane TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-06-21 US disclosed
EP-1883454-B1 AGENT FOR PERMANENT HAIR WAVING CONTAINING HETEROCYCLIC MERCAPTO COMPOUND SHOWA DENKO KK (JP) 2009-11-04 EP disclosed
US-20090270516-A1 Process for Producing Optically Active Theaspirane TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-29 US disclosed
US-20090208439-A1 Agent for Permanent Hair Waving Containing Heterocyclic Mercapto Compound SHOWA DENKO K.K. (JP) 2009-08-20 US disclosed
US-20090087401-A1 DEODORANT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-04-02 US disclosed
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; RESONAC CORPORATION (JP) 2008-04-10 US disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ALDH1A1 978/4885PRKD3 3021/4885PRKCG 3537/4885
US-20090270516-A1 Process for Producing Optically Active Theaspirane DHPS, ALDH7A1, FASN ALDH1A1 38/4885PRKD3 2944/4885PRKCG 2908/4885
US-20090208439-A1 Agent for Permanent Hair Waving Containing Heterocyclic Mercapto Compound NSD3, WNT3, MSRB3 ALDH1A1 165/4885PRKD3 1518/4885PRKCG 4772/4885
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; TST, CYSLTR1, CYSLTR2 ALDH1A1 672/4885PRKD3 3719/4885PRKCG 3794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.